Adaptive Biotechnologies Corp (ADPT) stock
ADPTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$28.49+0.62 (+2.22%)
Close on Nov 17, 2026Market cap $4.55BP/E –Yield –
Adaptive Biotechnologies price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Adaptive Biotechnologies's price to book ratio was 33.3× on Nov 11, 2026, against 14.7× a year earlier. Over the last 5 years it ranged from 1.2× to 33.3×, with a median of 3.1×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 33.3× | +21.2 |
| 2025 | Dec 31, 2025 | 12.1× | +8.2 |
| 2024 | Dec 31, 2024 | 4.0× | +2.0 |
| 2023 | Dec 29, 2023 | 2.0× | −0.3 |
| 2022 | Dec 30, 2022 | 2.2× | −3.8 |
| 2021 | Dec 31, 2021 | 6.1× | −4.3 |
| 2020 | Dec 31, 2020 | 10.4× | +4.1 |
| 2019 | Dec 31, 2019 | 6.3× | – |
See a number that looks wrong?